News

Filed in the US District Court for the Southern District of New York, the plaintiffs in the lawsuit are Elyse Dickerson and Susan Orr. They claim that the

Under the deal, the two parties will share intellectual property and jointly fund ten research projects, resulting in the design of multiple new inhibitors of the MTH1 protein,

As part of the deal, Roche will provide study drug and Celldex will be responsible for conducting and funding the trial, which is scheduled to be initiated later

In 2008, Lupin acquired 60% equity stake in PD, which is involved in distribution of a range of branded, generic prescription medicines and over-the-counter (OTC) products in South

The combined company will be responsible for developing new medicines that address unmet medical needs in critical therapeutic areas and is expected to have combined annual pro forma

Jakavi is the first targeted treatment approved by the EC for these patients in the European Union (EU) who are resistant to or intolerant of hydroxyurea. The European

The MVA Ebola Zaire vaccine candidate is expected to be used in a Phase I clinical trial being supported by a grant from the Wellcome Trust and the

The Canadian group will use Cannigistics’ software and information technology platform to gather, store, analyze and report on the results of the trials. This technology platform will help

The approval allows the new line of products to be distributed in the US into big box retail chain stores as well as facilitate entry into more regulated